- Karen M. Alsante, PhD, Research Fellow, PFIZER*
- Steven Baertschi, PhD, Research Fellow, ELI LILLY & COMPANY*
- Dan W. Reynolds, PhD, Manager, Chemical Development Analytical Sciences, GLAXOSMITHKLINE
- Dinos Santifianos, PhD, Principal Scientist, Analytical R&D, PFIZER
- Mark Kleinman, PhD, Manager, Early Phase Project Analysis and Degradation Chemistry, GLAXOSMITHKLINE*
- Rhonda A. Jackson, PhD, Principal Scientist, JOHNSON & JOHNSON
- Christopher M. Riley, PhD, President, RILEY AND RABEL CONSULT ING SERVICES, LLC
- Bernard A. Olsen, PhD, Consultant, OLSEN PHARMACEUTICAL CONSULTING*
- Li Li, PhD, Senior Research Chemist, MERCK
- Alan P McKeown, PhD, Senior Principal Scientist, PFIZER
- Kevin L. Facchine, PhD, Structural and Degradation Chemistry, Chemical Development Analytical Sciences, GLAXOSMITHKLINE
- Allen C. Templeton, PhD, Sr. Director, Basic Pharmaceutical Sciences, MERCK
- Michael Watkins, PhD, Senior Research Scientist, ELI LILLY & COMPANY
- Robert A. Reed, PhD, Executive Director, CMC and Technical Operations, CELSION CORPORATION*
- Eric Nelson, PhD, Principal Scientist, JOHNSON & JOHNSON*
- Darren L. Reid, PhD, Senior Scientist, AMGEN
- Andreas Abend, PhD, Associate Director, MERCK
- Leonardo Allain, PhD, Research Fellow, MERCK SHARP & DOHME
- Pat Jansen, PhD, ELI LILLY & COMPANY*
- Kenneth C. Waterman, PhD, Research Fellow, PFIZER
* With Special Thanks to the 2010 Forced Degradation Advisory Board |
